查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1585581

生物製药物流市场：依产品、运输、运输方式 - 全球预测 2025-2030

Bio-Pharmaceutical Logistics Market by Product (Branded Drugs, Generic Drugs), Transport (Cold-Chain Transport, Non Cold-Chain Transport), Mode of Transportation - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物製药物流市场价值为152.1亿美元，预计到2024年将达到169.2亿美元，复合年增长率为11.29%，到2030年将达到321.8亿美元。

生物医学物流领域包括药品和生技药品的运输、储存和配送，需要严格的温度控制、特殊处理和及时交付。从製造商到医院、药房和诊所等最终用户，需要保持温度敏感疫苗、生技药品和复杂药物的完整性和有效性，这凸显了该行业的重要性。该领域的关键应用包括低温运输物流、供应链管理和货运，确保产品安全到达并符合监管标准。对于广泛的最终用途，包括製药公司、医疗保健提供者和研究机构，高效的物流使药品更容易取得和取得。

主要市场统计
基准年[2023] 152.1亿美元
预测年份 [2024] 169.2亿美元
预测年份 [2030] 321.8亿美元
复合年增长率（%） 11.29%

市场成长受到药物研发活动活性化、世界慢性病盛行率增加以及个人化医疗出现的显着影响。生技药品和生物相似药的激增，以及先进包装技术和即时资料监控解决方案的进步，为向该市场提供创新服务提供了重大机会。为了利用这些机会，企业应专注于实施下一代物流技术，例如用于增强追踪的物联网和人工智慧以及用于透明供应链的区块链。然而，挑战包括高昂的营运成本、严格的监管要求以及处理生技药品的复杂性，这些可能会对市场进入和扩张造成障碍。

在创新方面，企业可以考虑投资更永续、更环保的物流解决方案，以解决环境问题。这包括开发更有效率的冷藏解决方案以及在供应链中利用可再生能源。此外，与高科技公司合作开发简化物流业务的整合数位平台可以提供竞争优势。该市场的特点是竞争激烈、技术进步迅速，需要敏捷性和策略伙伴关係才能保持领先。产业参与者有潜力提高供应链透明度和效率、重新定义竞争动态并优化市场覆盖范围。

市场动态：揭示快速发展的生物製药物流市场的关键市场洞察

供需的动态交互作用正在改变生物製药物流市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 生物製药产业对细胞疗法、疫苗和血液製品的需求不断增长
    • 高销售量带动全球生物製药进出口需求
    • 医疗保健领域的及时支援越来越重要
  • 市场限制因素
    • 运输成本高
  • 市场机会
    • 物流持续创新与云端运算融合
    • 外包运输服务的需求不断成长
  • 市场挑战
    • 产品效率低和定价政策波动

波特五力：驾驭生物製药物流市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解生物製药物流市场的外部影响

外部宏观环境因素对生物医学物流市场的绩效动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解生物製药物流市场的竞争格局

对生物製药物流市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵生物物流市场供应商的绩效评估

FPNV 定位矩阵是评估生物製药物流市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了生物製药物流市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，生物製药物流市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 生物製药产业对细胞疗法、疫苗和血液製品的需求不断增长
      • 销售量高 全球生物医药进出口需求增加
      • 医疗保健领域的及时支援变得越来越重要
    • 抑制因素
      • 运输成本高
    • 机会
      • 云端运算物流与整合持续创新
      • 外包运输服务的需求不断成长
    • 任务
      • 产品效率低和定价政策波动
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章生物製药物流市场：副产品

  • 品牌药品
  • 学名药

第七章 生物医学物流市场运输

  • 低温运输运输
  • 非低温运输运输

第八章生物医学物流市场：依交通途径

  • 空运
  • 铁路运输
  • 陆运
  • 海运

第九章美洲生物医药物流市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太生物医学物流市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲生物医学物流市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AmerisourceBergen Corporation
  • Bio Pharma Logistics
  • BL Turkey
  • CH Robinson Worldwide, Inc.
  • CAVALIER LOGISITICS
  • Ceva Logistics LLC
  • DB Schenker AG
  • Deutsche Post DHL Group
  • Fedex Corporation
  • Kerry Logistics Network Limited
  • Kuhne+Nagel Management AG
  • Nippon Express Co., Ltd.
  • Sentry BioPharma Services, Inc.
  • United Parcel Service of America, Inc.
Product Code: MRR-437D459587C9

The Bio-Pharmaceutical Logistics Market was valued at USD 15.21 billion in 2023, expected to reach USD 16.92 billion in 2024, and is projected to grow at a CAGR of 11.29%, to USD 32.18 billion by 2030.

The bio-pharmaceutical logistics sector encompasses the transportation, storage, and distribution of drugs and biologics that require stringent temperature controls, specialized handling, and timely deliveries. This industry's criticality is underscored by the necessity to maintain the integrity and efficacy of temperature-sensitive vaccines, biologics, and complex medicines from manufacturers to end-users, including hospitals, pharmacies, and clinics. Key applications within this domain include cold chain logistics, supply chain management, and freight forwarding, ensuring that products arrive safely and in compliance with regulatory standards. The end-use scope is expansive, spanning pharmaceutical companies, healthcare providers, and research organizations that rely on efficient logistics to facilitate the accessibility and availability of medications.

KEY MARKET STATISTICS
Base Year [2023] USD 15.21 billion
Estimated Year [2024] USD 16.92 billion
Forecast Year [2030] USD 32.18 billion
CAGR (%) 11.29%

Market growth is significantly influenced by increased pharmaceutical R&D activities, a rise in the global incidences of chronic diseases, and the advent of personalized medicine. The proliferation of biologics and biosimilars, alongside advancements in packaging technologies and real-time data monitoring solutions, present substantial opportunities for innovative service offerings in this market. To leverage these opportunities, companies should focus on adopting next-generation logistics technologies, such as IoT and AI for enhanced tracking, and blockchains for transparent supply chains. However, challenges include high operational costs, stringent regulatory requirements, and the complexity of handling biologics, which can pose barriers to market entry and expansion.

In terms of innovation, companies can explore investing in more sustainable and eco-friendly logistics solutions to address environmental concerns. This includes developing more efficient cold storage solutions and utilizing renewable energy sources within the supply chain. Additionally, collaborations with tech firms for integrated digital platforms that streamline logistics operations could offer a competitive edge. The market is characterized by robust competition and rapid technological advancements, necessitating agility and strategic partnerships to remain ahead. Therein lies an opportunity for industry players to enhance supply chain transparency and efficiency, potentially redefining competitive dynamics and optimizing market reach in the bio-pharmaceutical logistics sphere.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bio-Pharmaceutical Logistics Market

The Bio-Pharmaceutical Logistics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expansion in the demand for cellular therapies, vaccines and blood products in the bio-pharmaceutical industry
    • High sales drive the demand of global export import of Bio-pharmaceutical product
    • Rising importance of fast-track assistance in the healthcare sector
  • Market Restraints
    • High cost of transportation
  • Market Opportunities
    • Ongoing innovations in the logistics and integration of cloud computing
    • Growing demand for outsourcing transportation services
  • Market Challenges
    • Inefficient products and fluctuation in the pricing policies

Porter's Five Forces: A Strategic Tool for Navigating the Bio-Pharmaceutical Logistics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bio-Pharmaceutical Logistics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bio-Pharmaceutical Logistics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bio-Pharmaceutical Logistics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bio-Pharmaceutical Logistics Market

A detailed market share analysis in the Bio-Pharmaceutical Logistics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bio-Pharmaceutical Logistics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bio-Pharmaceutical Logistics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bio-Pharmaceutical Logistics Market

A strategic analysis of the Bio-Pharmaceutical Logistics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bio-Pharmaceutical Logistics Market, highlighting leading vendors and their innovative profiles. These include AmerisourceBergen Corporation, Bio Pharma Logistics, BL Turkey, C.H. Robinson Worldwide, Inc., CAVALIER LOGISITICS, Ceva Logistics LLC, DB Schenker AG, Deutsche Post DHL Group, Fedex Corporation, Kerry Logistics Network Limited, Kuhne + Nagel Management AG, Nippon Express Co., Ltd., Sentry BioPharma Services, Inc., and United Parcel Service of America, Inc..

Market Segmentation & Coverage

This research report categorizes the Bio-Pharmaceutical Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Branded Drugs and Generic Drugs.
  • Based on Transport, market is studied across Cold-Chain Transport and Non Cold-Chain Transport.
  • Based on Mode of Transportation, market is studied across Air Shipping, Rail Shipping, Road Shipping, and Sea Shipping.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expansion in the demand for cellular therapies, vaccines and blood products in the bio-pharmaceutical industry
      • 5.1.1.2. High sales drive the demand of global export import of Bio-pharmaceutical product
      • 5.1.1.3. Rising importance of fast-track assistance in the healthcare sector
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of transportation
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovations in the logistics and integration of cloud computing
      • 5.1.3.2. Growing demand for outsourcing transportation services
    • 5.1.4. Challenges
      • 5.1.4.1. Inefficient products and fluctuation in the pricing policies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bio-Pharmaceutical Logistics Market, by Product

  • 6.1. Introduction
  • 6.2. Branded Drugs
  • 6.3. Generic Drugs

7. Bio-Pharmaceutical Logistics Market, by Transport

  • 7.1. Introduction
  • 7.2. Cold-Chain Transport
  • 7.3. Non Cold-Chain Transport

8. Bio-Pharmaceutical Logistics Market, by Mode of Transportation

  • 8.1. Introduction
  • 8.2. Air Shipping
  • 8.3. Rail Shipping
  • 8.4. Road Shipping
  • 8.5. Sea Shipping

9. Americas Bio-Pharmaceutical Logistics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bio-Pharmaceutical Logistics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bio-Pharmaceutical Logistics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AmerisourceBergen Corporation
  • 2. Bio Pharma Logistics
  • 3. BL Turkey
  • 4. C.H. Robinson Worldwide, Inc.
  • 5. CAVALIER LOGISITICS
  • 6. Ceva Logistics LLC
  • 7. DB Schenker AG
  • 8. Deutsche Post DHL Group
  • 9. Fedex Corporation
  • 10. Kerry Logistics Network Limited
  • 11. Kuhne + Nagel Management AG
  • 12. Nippon Express Co., Ltd.
  • 13. Sentry BioPharma Services, Inc.
  • 14. United Parcel Service of America, Inc.

LIST OF FIGURES

  • FIGURE 1. BIO-PHARMACEUTICAL LOGISTICS MARKET RESEARCH PROCESS
  • FIGURE 2. BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIO-PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIO-PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIO-PHARMACEUTICAL LOGISTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIO-PHARMACEUTICAL LOGISTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD-CHAIN TRANSPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY NON COLD-CHAIN TRANSPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR SHIPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RAIL SHIPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD SHIPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA SHIPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 145. BIO-PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. BIO-PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023